|
|
Article: Molecular Insight Pharmaceuticals Awarded Three NIH Grants; Collaborations with McLean Hospital and Syracuse University to Research CNS Disorders and Infectious Disease.
- Article from:
- Business Wire
- Article date:
- October 16, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
BIOWIRE2K
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 16, 2003
Molecular Insight Pharmaceuticals, Inc. announced funding from the National Institutes of Health for three new research projects. Two grants will be shared with McLean Hospital and focus on the identification and characterization of central nervous system disorders. The third grant supports research with Syracuse University for the development of new radiopharmaceuticals for the rapid visualization of infectious disease.
One award from the National Institute of Neurological Disorders and Stroke will fund development of new ...